Ovarian Neoplasm
Oncology·MeSH: Ovarian Neoplasms
Prevalence
24.0 / 100K
Incidence
10.6 / 100K/yr
9 drugs in development·4 companies·1 clinical trial
Drug Pipeline by Phase
Compare drugs
Frequently asked questions
How many drugs are in development for Ovarian Neoplasm?
BioSniper tracks 9 drugs in development for Ovarian Neoplasm across 4 companies.
How many clinical trials target Ovarian Neoplasm?
There are 1 clinical trial targeting Ovarian Neoplasm tracked by BioSniper.
What is the prevalence of Ovarian Neoplasm?
The estimated prevalence of Ovarian Neoplasm is approximately 24.0 per 100,000 population.
Deep-dive into Ovarian Neoplasm
Full trial data, competitive analysis, and AI-powered pipeline tracking.
Start Free Analysis